JP2023514452A5 - - Google Patents
Info
- Publication number
- JP2023514452A5 JP2023514452A5 JP2022550908A JP2022550908A JP2023514452A5 JP 2023514452 A5 JP2023514452 A5 JP 2023514452A5 JP 2022550908 A JP2022550908 A JP 2022550908A JP 2022550908 A JP2022550908 A JP 2022550908A JP 2023514452 A5 JP2023514452 A5 JP 2023514452A5
- Authority
- JP
- Japan
- Prior art keywords
- binding
- cov
- scaffold
- sars
- spike protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981453P | 2020-02-25 | 2020-02-25 | |
| US62/981,453 | 2020-02-25 | ||
| US202063002249P | 2020-03-30 | 2020-03-30 | |
| US63/002,249 | 2020-03-30 | ||
| US202062706225P | 2020-08-05 | 2020-08-05 | |
| US62/706,225 | 2020-08-05 | ||
| US202063091291P | 2020-10-13 | 2020-10-13 | |
| US63/091,291 | 2020-10-13 | ||
| PCT/US2021/019739 WO2021173879A1 (en) | 2020-02-25 | 2021-02-25 | Identification of biomimetic viral peptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023514452A JP2023514452A (ja) | 2023-04-05 |
| JP2023514452A5 true JP2023514452A5 (https=) | 2024-03-05 |
Family
ID=77492020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550908A Withdrawn JP2023514452A (ja) | 2020-02-25 | 2021-02-25 | 生体模倣ウイルスペプチドの特定及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230242592A1 (https=) |
| EP (1) | EP4110366A4 (https=) |
| JP (1) | JP2023514452A (https=) |
| KR (1) | KR20220158723A (https=) |
| CN (1) | CN115461068A (https=) |
| AU (1) | AU2021227918A1 (https=) |
| CA (1) | CA3172878A1 (https=) |
| IL (1) | IL295863A (https=) |
| WO (1) | WO2021173879A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250107297A (ko) | 2020-04-02 | 2025-07-11 | 리제너론 파아마슈티컬스, 인크. | 항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편 |
| US20230218742A1 (en) * | 2020-05-22 | 2023-07-13 | Riken | Multiple antigenic peptide against coronavirus and immunostimulating composition containing the same |
| BR112022024662A2 (pt) | 2020-06-03 | 2023-04-04 | Regeneron Pharma | Métodos para tratamento ou prevenção de infecções por sars-cov-2 e covid-19 com anticorpos de glicoproteína spike anti-sars-cov-2 |
| US12496470B2 (en) | 2021-07-14 | 2025-12-16 | Regeneron Pharmaceuticals, Inc. | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments |
| IL311504A (en) | 2021-09-17 | 2024-05-01 | David Kotlyar | Oral vaccination using dental bacteria and peptides to prevent infection with COVID-19 |
| IT202200025416A1 (it) * | 2022-12-13 | 2024-06-13 | Univ Pisa | Biosensore per la rilevazione di particelle virali |
| CN117153245B (zh) * | 2023-10-18 | 2024-03-19 | 无锡市疾病预防控制中心 | 预测新型冠状病毒S蛋白RBD区域与hACE2受体相互作用的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10676511B2 (en) * | 2015-09-17 | 2020-06-09 | Ramot At Tel-Aviv University Ltd. | Coronaviruses epitope-based vaccines |
| AU2017378427A1 (en) * | 2016-12-14 | 2019-06-20 | Ligandal, Inc. | Methods and compositions for nucleic acid and protein payload delivery |
| US11365239B2 (en) * | 2020-03-20 | 2022-06-21 | Tsb Therapeutics (Beijing) Co., Ltd. | Anti-SARS-COV-2 antibodies and uses thereof |
-
2021
- 2021-02-25 CA CA3172878A patent/CA3172878A1/en active Pending
- 2021-02-25 KR KR1020227033145A patent/KR20220158723A/ko active Pending
- 2021-02-25 EP EP21760562.5A patent/EP4110366A4/en active Pending
- 2021-02-25 IL IL295863A patent/IL295863A/en unknown
- 2021-02-25 WO PCT/US2021/019739 patent/WO2021173879A1/en not_active Ceased
- 2021-02-25 JP JP2022550908A patent/JP2023514452A/ja not_active Withdrawn
- 2021-02-25 AU AU2021227918A patent/AU2021227918A1/en active Pending
- 2021-02-25 CN CN202180031498.6A patent/CN115461068A/zh active Pending
-
2022
- 2022-08-24 US US17/822,099 patent/US20230242592A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023514452A5 (https=) | ||
| ES2742739T3 (es) | Proteínas de fusión para uso como mejoradores inmunogénicos para inducir respuestas de células T específicas de antígenos | |
| ES2258796T3 (es) | Proteinas de fusion que contienen proteinas de estres para inducir respuestas inmunitarias. | |
| JP2022533318A5 (https=) | ||
| JP2023518038A5 (https=) | ||
| US9943583B2 (en) | Proline-rich peptides protective against S. pneumoniae | |
| JP2024522385A5 (https=) | ||
| AU2013250711A1 (en) | Long-acting oxyntomodulin variants and methods of producing same | |
| JP2008535800A5 (https=) | ||
| JP2008504012A5 (https=) | ||
| JP2011518179A5 (https=) | ||
| JP2020169191A5 (https=) | ||
| US20230338510A1 (en) | Novel coronavirus tandem epitope polypeptide vaccine and use thereof | |
| JP2015536134A5 (https=) | ||
| CN113260377B (zh) | 脂肽构建块和合成病毒样颗粒 | |
| CN105229025A (zh) | 位点特异性胰岛素缀合物 | |
| JP2024178193A (ja) | インスリン及びグルカゴンを含む薬学組成物 | |
| JP2023510864A (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体の持続型結合体の肺疾患の治療的使用 | |
| CN113769080B (zh) | 多肽免疫偶联物及其应用 | |
| JP4199421B2 (ja) | デキストラン−レプチン結合体、医薬組成物および関連方法 | |
| WO2008154867A1 (fr) | Composé immunogénique | |
| KR20200136774A (ko) | Rsv의 f 단백질-항체 복합체 및 이를 포함하는 조성물 | |
| JP2025519475A5 (https=) | ||
| EP1001978B1 (en) | Angiotensin derivatives | |
| JP2023534987A5 (https=) |